
|Articles|December 1, 2001
Foam Sclerotherapy Requires Fewer Injections
DALLAS - Although still in its infancy, foam sclerotherapy is a promising new treatment technique for telangiectatic, reticular, and varicose leg veins and has the potential to achieve higher rates of resolution with fewer injections compared with conventional sclerotherapy, Robert A. Weiss, M.D., said at the annual meeting of the American Society for Dermatologic Surgery.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
JAK Inhibitors Show Comparable Safety to TNF Antagonists
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5


















